ADRA2A Antikörper (C-Term)
-
- Target Alle ADRA2A Antikörper anzeigen
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADRA2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the C-terminal region of Human AR alpha2A.
- Isotyp
- IgG
- Top Product
- Discover our top product ADRA2A Primärantikörper
-
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 385-450) antibody
ADRA2A Reaktivität: Ratte WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (Internal Region) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 240-380) antibodyADRA2A Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 7-20), (Extracellular), (N-Term) antibodyADRA2A Reaktivität: Ratte, Maus WB, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (Internal Region) antibodyVerified ADRA2A Reaktivität: Human ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 331-380) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 218-374) antibodyADRA2A Reaktivität: Human ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (C-Term) antibodyADRA2A Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 223-256) antibodyADRA2A Reaktivität: Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal RB52053 unconjugated
anti-Alpha-2A Adrenergic Receptor (ADRA2A) (AA 118-152) antibodyADRA2A Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53330 unconjugated
-
- Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Andere Bezeichnung
- ADRA2A (ADRA2A Produkte)
- Synonyme
- ADRA2A antikoerper, AW122659 antikoerper, Adra-2 antikoerper, Adra-2a antikoerper, alpha(2A)AR antikoerper, alpha2-C10 antikoerper, alpha2A antikoerper, alpha2A-AR antikoerper, ADRA2 antikoerper, ADRA2R antikoerper, ADRAR antikoerper, ALPHA2AAR antikoerper, ZNF32 antikoerper, CA2-47 antikoerper, RATRG20 antikoerper, RG20 antikoerper, PORA2AR antikoerper, adrenoceptor alpha 2A antikoerper, alpha-2A adrenergic receptor-like antikoerper, adrenergic receptor, alpha 2a antikoerper, adra2a antikoerper, ADRA2A antikoerper, LOC100414445 antikoerper, Adra2a antikoerper
- Hintergrund
- ADA2A_HUMAN antibody, ADRA2 antibody, ADRA2A antibody, ADRA2R antibody, ADRAR antibody, Adrenergic alpha 2A receptor antibody, Alpha 2 adrenergic receptor subtype C10 antibody, Alpha 2A adrenergic receptor antibody, Alpha 2AAR subtype C10 antibody, Alpha-2 adrenergic receptor subtype C10 antibody, alpha-2-adrenergic receptor, platelet type antibody, Alpha-2A adrenergic receptor antibody, Alpha-2A adrenoceptor antibody, Alpha-2A adrenoreceptor antibody, Alpha-2AAR antibody, ALPHA2AAR antibody, OTTHUMP00000058849 antibody, ZNF32 antibody
- UniProt
- P08913
- Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
-
